SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-22-023249
Filing Date
2022-06-16
Accepted
2022-06-16 16:16:37
Documents
7
Effectiveness Date
2022-06-16

Document Format Files

Seq Description Document Type Size
1 S-8 brhc10038757_s8.htm S-8 37796
2 EXHIBIT 5.1 brhc10038757_ex5-1.htm EX-5.1 6606
3 EXHIBIT 23.2 brhc10038757_ex23-2.htm EX-23.2 2708
4 EXHIBIT 99.1 brhc10038757_ex99-1.htm EX-99.1 107765
5 EXHIBIT 107 brhc10038757_ex107.htm EX-FILING FEES 12719
6 image00001.jpg GRAPHIC 1866
7 image00002.jpg GRAPHIC 6950
  Complete submission text file 0001140361-22-023249.txt   181226
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265654 | Film No.: 221020787
SIC: 2834 Pharmaceutical Preparations